AnalystsAlbert LoweAlbert Lowe's Stock Forecasts
AnalystsAlbert Lowe
Sectors:
Industries:
Analyst Ranking
Top 37%
#1891 out of 5116 analysts
Average Return
+12.67%
Win Rate
44%4 out of 9
Risk vs Reward
Poor
Good
Albert Lowe's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Opus Genetics IncIRD | +200.42% | $0.71 | $2.13 | 2025-04-11 - 2025-11-28 | Buy |
Lineage Cell Therapeutics IncLCTX | +42.53% | $0.87 | $1.24 | 2024-08-20 - 2025-08-19 | Buy |
Neurogene IncNGNE | +14.44% | $18.42 | $21.08 | 2025-06-17 - 2025-11-28 | Buy |
Cardiff Oncology IncCRDF | +2.84% | $2.11 | $2.17 | 2024-09-06 - 2025-09-05 | Buy |
Albert Lowe Analyst Color
Get additional color on Albert Lowe's coverage of popular stocks
Albert Lowe's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Neurogene IncNGNE | 1 | Buy | $50.00 | +137.19% | Initiates Coverage On | 5 months ago |
Atossa Therapeutics IncATOS | 1 | Buy | $4.00 | +414.80% | Initiates Coverage On | 6 months ago |
Opus Genetics IncIRD | 1 | Buy | $6.00 | +181.69% | Initiates Coverage On | 8 months ago |
Skye Bioscience IncSKYE | 2 | Buy | $14.00 | +968.70% | Maintains | 8 months ago |
Sab Biotherapeutics IncSABS | 1 | Buy | $11.00 | N/A | Initiates Coverage On | a year ago |
Cardiff Oncology IncCRDF | 1 | Buy | $8.00 | N/A | Initiates Coverage On | a year ago |
Lineage Cell Therapeutics IncLCTX | 1 | Buy | $4.00 | N/A | Initiates Coverage On | a year ago |
Pmv Pharmaceuticals IncPMVP | 1 | Buy | $6.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.